Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT01309594
Eligibility Criteria:
Inclusion Criteria: Outpatients or inpatients that are treated for HIV infection at AIDS Clinical Center of National Center for Global Health and Medicine who meet all criteria following:
* have cirrhosis with 7 or higher Child-Pugh Score in Child-Pugh Score B
* able to consent and willing to participate in the study
* under good control for HIV infection
Exclusion Criteria: Cases applicable to ANY condition of the following:
* Hepatocellular carcinoma (HCC), except for cases having been completely treated without history of recurrence
* Malignant tumors other than HCC
* Alcoholic liver disease (ALD)
* Hemoglobin under 8g/dL or Platelets under 20/ml at the registration
* Esophageal or gastric varices with a risk of bursting, except for cases with only cured history of such conditions
* Cases that cannot obtain the informed consent to autologous blood transfusion
* Pregnancy
* Renal dysfunction with 2mg/dL or higher serum creatinine
* Performance Status 3 or 4 (assessment excludes hemophilic arthritis related daily life limitations)
* Cases not fit for general anesthesia
* Other conditions considered not suitable for the study by doctors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT01309594
Study Brief:
Protocol Section:
NCT01309594